Partitioning of vasoactive intestinal polypeptide into lipid bilayers.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Biochimica et Biophysica Acta

• Publication date

  1994-05-11

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0005-2736(94)90183-XPMID 8172918
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of protein charge in protein-lipid interactions. pH-dependent changes of the electrophoretic mobility of liposomes through adsorption of water-soluble, globular proteins.

  1993cited by this paper
• Exhaustive exercise affects fluidity and alpha-tocopherol levels in brain synaptosomal membranes of normal and vitamin E supplemented rats

  1993cited by this paper
• Vasoactive intestinal peptide: its interactions with calmodulin and catalytic antibodies.

  1993cited by this paper
• Binding of basic peptides to acidic lipids in membranes: effects of inserting alanine(s) between the basic residues.

  1992cited by this paper
• Melittin-induced alterations in dynamic properties of human red blood cell membranes.

  1992cited by this paper
• Cleavage of vasoactive intestinal peptide at multiple sites by autoantibodies.

  1991cited by this paper
• The biophysics of peptide models of ion channels.

  1991cited by this paper
• ESR analysis with long-chain alkyl spin labels in bovine blood platelets. Relationship between the increase in membrane fluidity by alcohols and phenolic compounds and their inhibitory effects on aggregation.

  1990cited by this paper
• Melittin binding to mixed phosphatidylglycerol/phosphatidylcholine membranes.

  1990cited by this paper
• Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody.

  1989cited by this paper
• Development of helix-based vasoactive intestinal peptide analogues: identification of residues required for receptor interaction.

  1988cited by this paper
• Aqueous channels within apolar peptide aggregates: solvated helix of the alpha-aminoisobutyric acid (Aib)-containing peptide Boc-(Aib-Ala-Leu)3-Aib-OMe.2H2O.CH3OH in crystals.

  1988cited by this paper
• Peptides with affinity for membranes.

  1987cited by this paper
• Peptides with affinity for membranes.

  1987cited by this paper
• Induction of peptide conformation at apolar water interfaces. 1. A study with model peptides of defined hydrophobic periodicity

  1985cited by this paper
• Vasoactive intestinal polypeptide (VIP): current status.

  1984cited by this paper
• Behavior of amphipathic helices on analysis via matrix methods, with application to glucagon, secretin, and vasoactive intestinal peptide

  1983cited by this paper
• Lipid‐induced conformational changes in glucagon, secretin, and vasoactive intestinal peptide

  1982cited by this paper
• Hydrophobic and electrostatic interactions of myelin basic proteins with lipid. Participation of N-terminal and C-terminal portions.

  1981cited by this paper
• Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation.

  1978cited by this paper
• The function of sterols in membranes.

  1976cited by this paper
• A preferred conformation in the vasoactive intestinal peptide (VIP). Molecular architecture of gastrointestinal hormones

  1974cited by this paper
• Phase changes in the lipid moieties of sarcoplasmic reticulum membranes induced by temperature and protein conformational changes.

  1972cited by this paper
• Molecular motion in spin-labeled phospholipids and membranes.

  1971cited by this paper
• Single bilayer liposomes.

  1971cited by this paper

• Association of vasoactive intestinal peptide with polymer-grafted liposomes: structural aspects for pulmonary delivery.

  2007cites this paper
• Human VIP-α: A long-acting, biocompatible and biodegradable peptide nanomedicine for essential hypertension

  2006cites this paper
• Liposomal vasoactive intestinal peptide.

  2005cites this paper
• A Novel Formulation of VIP in Sterically Stabilized Micelles Amplifies Vasodilation In Vivo

  2004cites this paper
• Interactions of VIP with rigid phospholipid bilayers: implications for vasoreactivity.

  2003cites this paper
• Interactions of VIP, secretin and PACAP(1-38) with phospholipids: a biological paradox revisited.

  2003cites this paper
• Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats.

  2003influential citation
• Interactions of human secretin with sterically stabilized phospholipid micelles amplify peptide-induced vasodilation in vivo.

  2002cites this paper
• Phospholipids modulate the biophysical properties and vasoactivity of PACAP-(1--38).

  2002cites this paper
• Secretin self-assembles and interacts spontaneously with phospholipids in vitro.

  2002cites this paper
• Surface-active properties of vasoactive intestinal peptide*.

  2000cites this paper
• Conformation and vasoreactivity of VIP in phospholipids: effects of calmodulin.

  1999cites this paper
• Exogenous calmodulin potentiates vasodilation elicited by phospholipid-associated VIP in vivo.

  1999cites this paper
• Exogenous calmodulin potentiates vasodilation elicited by phospholipid-associated VIP in vivo.

  1999cites this paper
• Stabilization of Vasoactive Intestinal Peptide by Lipids 1

  1998cites this paper
• Vasodilation elicited by liposomal VIP is unimpeded by anti-VIP antibody in hamster cheek pouch.

  1998cites this paper
• Fatty acids and brain peptides.

  1998cites this paper
• Stabilization of vasoactive intestinal peptide by lipids.

  1998cites this paper
• Vasodilation elicited by liposomal VIP is unimpeded by anti-VIP antibody in hamster cheek pouch.

  1998cites this paper
• Functional reconstitution of membrane glycoproteins into lipid vesicles using lectin precipitation. Application to the VIP receptor.

  1998cites this paper
• Liposomal VIP attenuates phenylephrine- and ANG II-induced vasoconstriction in vivo.

  1998cites this paper
• Mechanisms of vasodilation elicited by VIP in sterically stabilized liposomes in vivo.

  1997cites this paper
• Development of a Novel Bioactive Formulation of Vasoactive Intestinal Peptide in Sterically Stabilized Liposomes

  1997cites this paper
• Encapsulation of VIP into liposomes restores vasorelaxation in hypertension in situ.

  1996cites this paper
• Encapsulation of vasoactive intestinal peptide into liposomes: effects on vasodilation in vivo.

  1995cites this paper
• The preparation of tissue-type Plasminogen Activator (t-PA) containing liposomes: entrapment efficiency and ultracentrifugation damage.

  1995cites this paper